Please assess the completion status of the following clinical trial:

Trial Title: An Audit of Patients With Crohn's Disease Treated With Infliximab (P06066)

Study Design Characteristics:
- Allocation: None
- Intervention Model: None
- Observational Model: CASE_ONLY
- Primary Purpose: None
- Time Perspective: RETROSPECTIVE
- Masking: None
- Phase: None
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* Diagnosis of Crohn's Disease.~* Over the age of 18 years.~* Must have received the first infusion of infliximab on or after 1st January 2003 (when the maintenance therapy license was granted).~* Must have received at least one infusion of infliximab.~* A minimum of 12 months data prior to, and 24 months data post infliximab exposure should be available in the medical records.~* Must have been under the care of the participating center for the entirety of the study period.~Exclusion Criteria:~* Should not have been involved in any clinical trial during the observational period (ie, a minimum of 12 months before and 24 months after first receiving infliximab).~* Should not have received any biologic therapy prior to infliximab.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Infliximab (Type: None): Infliximab as prescribed by a physician in normal practice for Crohn's disease

Based on this trial design, predict the completion outcome and termination type (if applicable).